Sherin Rouhani, MD PhD

28 posts

Sherin Rouhani, MD PhD banner
Sherin Rouhani, MD PhD

Sherin Rouhani, MD PhD

@srouhani1

Inpatient oncologist and immunologist at MGH. Opinions are my own.

Katılım Mart 2019
150 Takip Edilen116 Takipçiler
Sherin Rouhani, MD PhD retweetledi
Rohan Katipally
Rohan Katipally@RohanKatipally·
Proud to present our work, now online @JCOPO_ASCO: "STK11 Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage Non-Small Cell Lung Cancer" ascopubs.org/doi/full/10.12… So thankful for our numerous collaborators across multiple departments and institutions Tweetorial 👇
English
2
13
34
8.4K
Sherin Rouhani, MD PhD retweetledi
Patrick Forde
Patrick Forde@FordePatrick·
Patient-centered summary of the #CheckMate816 neoadjuvant chemo-immunotherapy clinical trial. This is a new treatment for patients with stage 1-3 non-small-cell lung cancer that can be removed by surgery. The summary may be useful for clinicians & patients. #lcsm @LUNGevity
Patrick Forde tweet media
English
13
112
316
0
Inas Abuali, MD
Inas Abuali, MD@inas_md·
Earlier today, my father passed away in the ICU from a severe COVID infection. Please wear a mask, get vaccinated and be kind to one another.
English
1.5K
2.3K
19.7K
0
Sherin Rouhani, MD PhD retweetledi
Balazs Lab
Balazs Lab@BalazsLab·
Here's what the data looked like for people who got Pfizer: 7/16
Balazs Lab tweet media
English
7
67
228
0
Sherin Rouhani, MD PhD retweetledi
Tatiana Prowell, MD
Tatiana Prowell, MD@tmprowell·
📣 #MedTwitter #FDA granted emerg use auth to AZ long-acting Ab cocktail (Evusheld) for #COVID19 PRE-exposure prophylaxis in mod-severe immunocompromised (age 12+ & 40+ kg). Two IM injections, may repeat q6 mos. At least 2w post vax. ⚠️ Not PEP/treatment fda.gov/media/154701/d…
Tatiana Prowell, MD tweet mediaTatiana Prowell, MD tweet media
English
3
14
25
0
Sherin Rouhani, MD PhD retweetledi
Jarushka Naidoo
Jarushka Naidoo@DrJNaidoo·
Interesting study ⁦@CCR_AACR⁩ shows high-dose steroids (>60mg pred) for early irAEs (within 8wks antiPD1) for melanoma is assoc with poorer: - post-irAE PFS - post-irAE OS validated by multinational cohort& confirmed by sensitivity analysis ⁦ clincancerres.aacrjournals.org/content/27/21/…
English
2
9
42
0
Sherin Rouhani, MD PhD retweetledi
Nik Joshi
Nik Joshi@Joshilabyale·
Excited for the opportunity to participate in the @EarlyImmunology series next Tuesday at 12pm ET. I’ll be talking on unpublished new models of peripheral T cell tolerance and how immune checkpoint blockade can lead to immunopathology.
Early Career Immunology@EarlyImmunology

Join us live next Tuesday 9am PT/12pm ET! Nikhil Joshi will present: "Blurring the line between T cell immunity and tolerance" youtube.com/watch?v=GDwG0h…

English
1
21
90
0
Sherin Rouhani, MD PhD
Sherin Rouhani, MD PhD@srouhani1·
Important work from @DoreenEzeife & team. Doing more testing up-front with liquid biopsy + tissue NGS actually SAVES the health system money, and more importantly gets patients the best first-line treatment. Time to update our standard workflow... @marinagarassino
Stephen V Liu, MD@StephenVLiu

#WCLC21 Congratulations to Dr. @DoreenEzeife and team. I do believe early integration of liquid biopsy is appropriate as it increases the odds of making the right treatment choice quickly, particularly since sequence of therapy is so critical. These data are icing on the cake.

English
0
0
3
0
Sherin Rouhani, MD PhD retweetledi
Ivy Riano, M.D.
Ivy Riano, M.D.@IvyLorena_Md·
📣Global Oncology Opportunity We are excited to launch our Project ECHO Global Oncology Tumor Board 2021-22 @DartmouthHitch: A unique platform that leverages learning, training and practice support to give voice to healthcare knowledge around the world Registration is free
Ivy Riano, M.D. tweet media
Lebanon, NH 🇺🇸 English
3
23
45
0

Keşfet

@SeanPitroda @SGutiontov @ajuloorimd @michaelsbinkley @BLoo_LT_SABR @RohanKatipally @JCOPO_ASCO @kreynoldsMD